Pay in 4 interest-free payments of $7.00 Learn more
Ships within 48 hours · Estimated delivery Aug 15 - Aug 20
In the STEP 1 trial, semaglutide 2.4mg produced an average loss of 14.9% of body weight over 68 weeks, compared to just 2.4% on placebo
Am.J Kidney Dis 1999;34(4):678-687
Nutrition and Exercise Interventions to Improve Body Composition for Persons With Overweight or Obesity Near Retirement Age: A Systematic Review and Network Meta-Analysis of Randomized Controlled Trials
2: receiving maximum dose 1 mg
Daily Oral GLP-1 Receptor Agonist Orforglipron for Adults with Obesity Obesity contributes to many of the world's leading causes of illness and death
US$ 20.13
US$ 23.23
US$ 22.09
